Blood coagulation function health management platform and method and storage medium

Through the non-invasive detection and personalized health management solution of the coagulation function health management platform, the problems of low accuracy of traditional coagulation function detection and lack of telemedicine guidance are solved, efficient and accurate coagulation function detection and personalized health management are achieved, and users are enhanced Experience.

CN119092123APending Publication Date: 2024-12-06重庆医科大学国际体外诊断研究院
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202411136803.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-19
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

In clinical diagnosis and treatment, traditional coagulation function testing has problems such as low detection accuracy, complex operation, inability to achieve comprehensive coagulation indicator detection, insufficient personalized services, lack of telemedicine guidance and data security risks, which reduces the user experience.

Method used

A health management platform for coagulation functions was designed, including mobile terminals with data interconnection, non-invasive coagulation detection devices and cloud servers. Through non-invasive collection of physiological signals, the coagulation data prediction model and evaluation model are used to generate health hazard reports, and formulate them based on characteristic information. Personalized health management solution, integrated telemedicine service system for data interoperability and secure transmission.

Benefits of technology

Realize non-invasive instant detection of coagulation function, reduces the complexity of detection operations, enhances detection accuracy, provides high-quality telemedicine guidance, improves user experience, and improves the health management of coagulation function through personalized health management solutions. Effect.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119092123A_ABST
    Figure CN119092123A_ABST
Patent Text Reader

Abstract

The invention provides a blood coagulation function health management platform and method and a storage medium, and the platform comprises a mobile terminal which is used for responding to a first detection operation, generating a detection instruction and obtaining to-be-detected user information; the noninvasive blood coagulation detection device is used for responding to the detection instruction, collecting a physiological signal of a to-be-detected user, and analyzing according to the physiological signal to obtain first blood coagulation data; the cloud server is used for storing historical blood coagulation data and inputting the first blood coagulation data and to-be-tested user information into a blood coagulation function evaluation model to generate a first health hidden danger report; and the remote medical service system is used for extracting the feature information of the first blood coagulation data, the historical blood coagulation data and the first health hidden danger report, and formulating a first health management scheme for the to-be-tested user according to the mapping relationship between the feature information and the health management scheme. According to the platform, the detection of the blood coagulation function and the remote medical guidance based on the health hidden danger corresponding to the blood coagulation function are quickly and accurately realized by utilizing a non-invasive instant detection technology.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of medical health management technology, and in particular to a coagulation function health management platform, method and storage medium. Background Art

[0002] With the continuous development of modern medical technology, coagulation function testing plays an increasingly important role in clinical diagnosis and treatment. Traditional coagulation function testing usually needs to be performed in hospitals or professional laboratories, involving invasive blood collection, complex sample processing procedures, and long waits for results, which not only brings inconvenience to patients, but also limits the timeliness and popularity of coagulation function testing.

[0003] At present, with the rapid development of smart phones and mobile Internet technology, mobile medical care and remote health management have become new hot spots in the medical field. As an indispensable tool in modern people's daily life, smart phones provide new possibilities for instant detection of coagulation function and remote health management with their portability, powerful computing power and rich applications. However, in related technologies, the coagulation function detection platform based on smart phones still has some limitations, such as low detection accuracy, complex operation, inability to detect all-round coagulation indicators, insufficient personalized services, lack of remote medical guidance, and data security risks, which reduce the user experience.

[0004] Therefore, it is urgent to develop an efficient and accurate all-round non-invasive instant detection of coagulation function and a personalized remote health management platform to enhance the user experience. Summary of the invention

[0005] In order to provide a basic understanding of some aspects of the disclosed embodiments, a brief summary is given below. The summary is not an extensive review, nor is it intended to identify key / critical components or delineate the scope of protection of these embodiments, but rather serves as a prelude to the detailed description that follows.

[0006] In view of the above-mentioned shortcomings of the prior art, the present invention discloses a coagulation function health management platform, method and storage medium, which are used to solve the technical problems of coagulation function detection accuracy, low efficiency and lack of remote medical guidance in the prior art.

[0007] In a first aspect, the present application provides a coagulation function health management platform, which includes a mobile terminal with data interconnection, a non-invasive coagulation detection device, a cloud server and a telemedicine service system; the mobile terminal is used to respond to a first detection operation, generate a detection instruction and send it to the non-invasive coagulation detection device, and obtain the user information to be tested and send it to the cloud server; the non-invasive coagulation detection device is used to respond to the detection instruction, collect the physiological signal of the user to be tested, obtain the first coagulation data according to the physiological signal analysis, and send it to the cloud server; the cloud server is used to store historical coagulation data, and input the first coagulation data and the user information to be tested into a coagulation function evaluation model, generate a first health hazard report, and feed it back to the mobile terminal, wherein the coagulation function evaluation model is obtained by training a coagulation data set that annotates the coagulation function status and user information; the telemedicine service system is used to extract the characteristic information in the first coagulation data, the historical coagulation data and the first health hazard report, and formulate a first health management plan for the user to be tested according to the mapping relationship between the characteristic information and the health management plan.

[0008] In one embodiment of the present invention, the non-invasive coagulation detection device includes: a sensor module, used to collect the physiological signals, wherein the physiological signals include impedance signals, blood flow resistance signals and piezoelectric signals; a signal processing module, used to perform signal preprocessing operations on the impedance signals, the blood flow resistance signals and the piezoelectric signals, wherein the signal preprocessing operations include at least one of signal amplification processing, filtering processing, denoising processing and correction processing; a data analysis module, used to input the preprocessed impedance signals, the blood flow resistance signals and the piezoelectric signals into a coagulation data prediction model to obtain the first coagulation data, wherein the coagulation data prediction model is obtained by training based on a signal set of labeled coagulation data, and the first coagulation data includes prothrombin time, activated partial thromboplastin time, thrombin time, fibrinogen concentration and D-dimer concentration.

[0009] In one embodiment of the present invention, the cloud server includes: a data processing module, used to perform data preprocessing operations on the first coagulation data, wherein the data preprocessing includes at least one of cleaning processing, denoising processing and normalization processing; a first coagulation function evaluation module, used to label the preprocessed first coagulation data according to the user information to be tested, and input the labeled first coagulation data into a coagulation function evaluation model to obtain a first coagulation function state, wherein the user information to be tested includes genetic information, physiological information and habit information; a first hidden danger assessment module, used to perform health hidden danger analysis on the first coagulation function state according to the user information to be tested, and generate the first health hidden danger report.

[0010] In one embodiment of the present invention, the characteristic information includes coagulation data trend characteristics and health hazard characteristics, and the telemedicine service system includes: an access module, used to obtain the first coagulation data, the historical coagulation data and the first health hazard report; a first health management module, used to analyze the changing trends of the first coagulation data and the historical coagulation data to obtain the coagulation data trend characteristics, and analyze the health hazards in the first health hazard report to obtain the health hazard characteristics, and generate the first health management plan based on the mapping relationship between the coagulation data trend characteristics, the health hazard characteristics and the health management plan, wherein the first health management plan includes at least one of diet recommendations, exercise recommendations, lifestyle recommendations and medication recommendations.

[0011] In one embodiment of the present invention, the cloud server also includes: an individual difference analysis module, which is used to construct a user portrait based on the user information to be tested, and analyze individual differences based on the user portrait; a verification module, which is used to perform coagulation function analysis on the historical coagulation data, determine the standard coagulation function state corresponding to the historical coagulation data, and calculate the predicted difference between the historical coagulation function state corresponding to the historical coagulation data and the standard coagulation function state; a calibration module, which is used to adjust the model parameters and model structure of the coagulation function evaluation model according to the individual differences and the predicted differences, so as to obtain a personalized coagulation function evaluation model for the user to be tested.

[0012] In one embodiment of the present invention, the cloud server also includes: a second health management module, which is used to input the first coagulation data, the first health hazard report, and the user information to be tested into a first health management model to obtain a second health management plan, wherein the first health management model is trained based on a first data set labeled with health advice, and the second health management plan includes at least one of diet advice, exercise advice, living habit advice, medical consultation guidance, and drug advice.

[0013] In one embodiment of the present invention, the mobile terminal also includes: an acquisition module, which is used to respond to the second detection operation and acquire a blood sample image of the fingertips of the user to be tested; an image analysis module, which is used to input the blood sample image into an image analysis model to obtain second coagulation data, wherein the image analysis model is trained based on a blood sample image set with annotated coagulation data, and the blood sample image set includes blood sample images under various light, skin color and shooting angles; a second coagulation function evaluation module, which is used to compare the second coagulation data with a preset coagulation data threshold and determine the second coagulation function status based on the comparison result; a second hidden danger evaluation module, which is used to perform health hidden danger analysis on the second coagulation function status based on the user information to be tested and generate a second health hidden danger report.

[0014] In one embodiment of the present invention, the mobile terminal also includes: a third health management module, used to input the second coagulation data, the second health hazard report and the user information to be tested into a second health management model to obtain an initial health management plan, wherein the second health management model is trained based on a second data set labeled with health advice, and the initial health management plan includes at least one of diet advice, exercise advice, lifestyle advice, medical consultation guidance and drug advice; an audit module, used to review the medical consultation guidance and the drug advice, and if the audit is passed, the initial health management plan is determined as the third health management plan; an update module, used to update the third health management plan in real time based on the latest second coagulation data, the second health hazard report and the user information to be tested.

[0015] In a second aspect, the present application provides a method for health management of coagulation function, the method comprising: in response to a first detection operation, obtaining user information, physiological signals and historical coagulation data of a user to be tested, wherein the user information to be tested includes genetic information, physiological information and habit information; inputting the physiological signal into a coagulation data prediction model to obtain the first coagulation data, wherein the coagulation data prediction model is trained based on a signal set of labeled coagulation data, and the first coagulation data includes prothrombin time, activated partial thromboplastin time, thrombin time, fibrinogen concentration and D-dimer concentration; according to the user to be tested The first coagulation data is labeled with user information, and the labeled first coagulation data is input into a coagulation function evaluation model to obtain a first coagulation function state, wherein the coagulation function evaluation model is trained based on a coagulation data set labeled with the coagulation function state and user information; a health hazard analysis is performed on the first coagulation function state according to the user information to be tested, and a first health hazard report is generated; characteristic information is extracted from the first coagulation data, the historical coagulation data and the first health hazard report, and a first health management plan is formulated for the user to be tested based on a mapping relationship between the characteristic information and the health management plan.

[0016] In a third aspect, the present application provides a computer-readable storage medium having a computer program stored thereon. When the computer program is executed by a processor of a computer, the computer executes the coagulation function health management method described in the second aspect.

[0017] As described above, the coagulation function health management platform, method and storage medium provided by the embodiments of the present invention have the following beneficial effects:

[0018] First, a mobile terminal responds to a first detection operation, generates a detection instruction and obtains information of the user to be tested, then a non-invasive coagulation detection device responds to the detection instruction, collects physiological signals of the user to be tested, and obtains first coagulation data based on physiological signal analysis, and then the cloud server inputs the first coagulation data and the user information to be tested into a coagulation function evaluation model to generate a first health hazard report, and finally the telemedicine service system can extract the first coagulation data, the historical coagulation data and the characteristic information in the first health hazard report, and formulate a first health management plan for the user to be tested based on the mapping relationship between the characteristic information and the health management plan, and integrates a mobile terminal, a non-invasive coagulation detection device, a cloud server and a telemedicine service system with data interconnection, and uses a mobile terminal to control the non-invasive coagulation detection device for detection, thereby realizing non-invasive instant detection of coagulation function and reducing the complexity of the detection operation, and combining the user information to be tested, using the coagulation function evaluation model to evaluate health hazards, thereby enhancing the accuracy of coagulation function detection, so that the telemedicine service system can formulate a health management plan based on comprehensive and reliable coagulation data and health hazard reports, and achieve high-quality telemedicine guidance, thereby improving user experience.

[0019] It should be understood that the foregoing general description and the following detailed description are exemplary and explanatory only and are not restrictive of the present application. BRIEF DESCRIPTION OF THE DRAWINGS

[0020] The drawings herein are incorporated into the specification and constitute a part of the specification, showing embodiments consistent with the present application, and together with the specification, are used to explain the principles of the present application. Obviously, the drawings described below are only some embodiments of the present application, and for those of ordinary skill in the art, other drawings can be obtained based on these drawings without creative work. In the drawings:

[0021] Figure 1 is a block diagram of a coagulation function health management platform shown in an exemplary embodiment of the present application;

[0022] Figure 2 is a block diagram of another coagulation function health management platform shown in an exemplary embodiment of the present application;

[0023] Figure 3 It is a flow chart of a method for healthy management of coagulation function shown as an exemplary embodiment of the present application. DETAILED DESCRIPTION

[0024] The following will describe the embodiments of the present invention with reference to the accompanying drawings and preferred embodiments. Those skilled in the art can easily understand other advantages and effects of the present invention from the contents disclosed in this specification. The present invention can also be implemented or applied through other different specific embodiments, and the details in this specification can also be modified or changed in various ways based on different viewpoints and applications without departing from the spirit of the present invention. It should be understood that the preferred embodiments are only for illustrating the present invention, not for limiting the scope of protection of the present invention.

[0025] It should be noted that the illustrations provided in the following embodiments are only used to illustrate the basic concept of the present invention in a schematic manner, and thus the illustrations only show components related to the present invention rather than being drawn according to the number, shape and size of components in actual implementation. In actual implementation, the type, quantity and proportion of each component may be changed arbitrarily, and the component layout may also be more complicated.

[0026] In the following description, numerous details are discussed to provide a more thorough explanation of the embodiments of the present invention. However, it is obvious to those skilled in the art that the embodiments of the present invention can be implemented without these specific details. In other embodiments, well-known structures and devices are shown in the form of block diagrams rather than in detail to avoid making the embodiments of the present invention difficult to understand.

[0027] Traditional coagulation function tests usually need to be performed in hospitals or professional laboratories, involving invasive blood collection, complex sample processing procedures, and long waiting times for results, which not only brings inconvenience to patients, but also limits the timeliness and popularity of coagulation function tests. With the rapid development of smart phones and mobile Internet technology, mobile medical care and remote health management have become new hotspots in the medical field. As an indispensable tool in modern people's daily life, smart phones provide new possibilities for instant detection of coagulation function and remote health management with their portability, powerful computing power, and rich applications. However, the inventors of this application have found that the coagulation function detection platform based on smart phones still has some limitations, such as low detection accuracy, complex operation, inability to detect all-round coagulation indicators, insufficient personalized services, lack of remote medical guidance, and data security risks, which reduce the user experience.

[0028] Therefore, the present application proposes a coagulation function health management platform to solve at least one of the above-mentioned technical problems.

[0029] See also Figure 1 , Figure 1 It is a block diagram of a coagulation function health management platform shown in an exemplary embodiment of the present application. It should be understood that this embodiment does not limit the implementation environment to which the platform is applicable.

[0030] like Figure 1 As shown, in an exemplary embodiment, the coagulation function health management platform includes at least a data interconnected mobile terminal 110, a non-invasive coagulation detection device 120, a cloud server 130 and a remote medical service system 140, and each part performs data transmission and interaction through wireless communication methods such as Bluetooth, mobile thermoelectric or mobile network. The detailed introduction is as follows:

[0031] The mobile terminal 110 is used to respond to the first detection operation, generate a detection instruction and send it to the non-invasive coagulation detection device, and obtain the user information to be tested and send it to the cloud server.

[0032] It should be noted that the mobile terminal can be a mobile phone, notebook, tablet computer, etc., with corresponding applications installed, and has functions such as user registration and login, device connection, data reception and display, health risk assessment, personalized suggestion push, and online consultation. Users can view their coagulation function test data in real time through the application, understand the health risks of coagulation function, and adjust their lifestyle or seek medical help according to the health management plan provided by the application. In addition, the application also supports data synchronization with the cloud server, so that users can access historical data such as coagulation data and health risks anytime and anywhere.

[0033] In this embodiment, the mobile terminal provides a simple and intuitive operation interface, and the user can trigger the coagulation function test with one click, generate a test instruction and send it to the non-invasive coagulation detection device 120 to start the non-invasive blood function detection device 120, and obtain the user information to be tested based on the user's registration information, editing information, etc. The user information to be tested includes genetic information, physiological information and habit information, including genetic information such as genetic disease history, genetic disease type, etc., physiological information such as age, gender, height, weight and other physical signs data, and habit information such as exercise habits, eating habits, smoking and drinking conditions, etc.

[0034] The non-invasive coagulation detection device 120 is used to respond to the detection instruction, collect the physiological signal of the user to be tested, obtain the first coagulation data according to the physiological signal analysis, and send it to the cloud server.

[0035] In this embodiment, the non-invasive coagulation detection device 120 responds to the detection instruction, collects the physiological signals of the user to be tested in a real-time and non-invasive manner, and obtains the first coagulation data based on the physiological signal analysis. It can realize the real-time non-invasive detection of coagulation data without collecting blood samples, replacing the traditional cumbersome detection method, so that the cloud server 130 can provide users with accurate and reliable coagulation function and health hazard assessment results in a very short time, thereby significantly improving the detection efficiency and user experience.

[0036] In one embodiment, see Figure 2 , Figure 2 FIG. 1 is a block diagram of another coagulation function health management platform shown in an exemplary embodiment of the present application. Figure 2 As shown, the non-invasive coagulation detection device 120 includes: a sensor module 121, which is used to collect physiological signals, and the physiological signals include impedance signals, blood flow resistance signals and piezoelectric signals; a signal processing module 122, which is used to perform signal preprocessing operations on the impedance signals, blood flow resistance signals and piezoelectric signals, wherein the signal preprocessing operations include at least one of signal amplification processing, filtering processing, denoising processing and correction processing; a data analysis module 123, which is used to input the preprocessed impedance signals, blood flow resistance signals and piezoelectric signals into a coagulation data prediction model to obtain first coagulation data, wherein the coagulation data prediction model is obtained by training based on a signal set of labeled coagulation data, and the first coagulation data includes prothrombin time, activated partial thromboplastin time, thrombin time, fibrinogen concentration and D-dimer concentration.

[0037] In this embodiment, the non-invasive coagulation detection device 120 uses a biocompatible flexible material as a substrate, and its elasticity and flexibility can adaptively fit the skin curvature of different parts, and the micro-grooves and protrusions are designed so that the flexible substrate further enhances the contact area and fit with the skin, thereby ensuring the accuracy of signal acquisition. At the same time, the flexible material is a material with breathable and sweat-wicking functions, which effectively improves the wearing experience of the user to be tested.

[0038] In addition, the sensor module 121 in the non-invasive coagulation detection device 120 is highly integrated with a micro biosensor array, which integrates multiple types of sensors, including bioimpedance sensors, piezoelectric sensors, etc., to collect various physiological signals related to coagulation function. The micro biosensor array also has a dynamic adjustment function, which can automatically adjust the working parameters such as current intensity, radio frequency frequency, etc. according to the real-time skin state to ensure the accuracy of the detection. The current is applied to the skin through the bioimpedance sensor, and the voltage change caused by it is measured to calculate the bioimpedance, obtain the impedance signal, and further calculate the blood flow resistance to obtain the blood flow resistance signal; the mechanical stress (such as the change in tissue tension generated during blood coagulation) is converted into an electrical signal through the piezoelectric sensor to obtain a piezoelectric signal.

[0039] In this embodiment, the signal processing module 122 performs signal preprocessing operations on the impedance signal, the blood flow resistance signal and the piezoelectric signal to improve the signal-to-noise ratio, thereby further ensuring the accuracy of the coagulation data prediction.

[0040] In this embodiment, the coagulation data prediction model is obtained by training the signal set of annotated coagulation data, and a mapping relationship between coagulation data and physiological signals is established by training a large amount of annotated data using a machine learning algorithm (such as a support vector machine, a random forest, a neural network, etc.). The data analysis module 123 inputs the physiological signal into the coagulation data prediction model, and the model is implemented by a multi-layer perceptron network. After the input layer receives the pre-processed physiological signal, the hidden layer extracts the features related to the coagulation data from the physiological signal, such as the impedance change in a specific frequency band, the change in blood flow resistance and the waveform characteristics of the piezoelectric signal, etc., to predict the coagulation data, thereby ensuring the accuracy of the first coagulation data obtained.

[0041] In addition, the first coagulation data obtained include prothrombin time, activated partial thromboplastin time, thrombin time, fibrinogen concentration and D-dimer concentration, realizing a full range of coagulation function testing.

[0042] It should also be noted that the first coagulation test data obtained by the non-invasive coagulation test device 120 can be fed back to the mobile terminal for the user to be tested to view. The non-invasive coagulation test device 120 is integrated with the cloud server 130 to achieve remote storage, sharing and analysis of the first coagulation data. The user to be tested can access his or her historical data through the cloud server 130 to perform trend analysis and comparison to more comprehensively understand the changes in his or her coagulation function.

[0043] In a possible embodiment, the non-invasive coagulation detection device 120 is equipped with a microprocessor. In addition to controlling the data acquisition and processing of the micro-biosensor array, the microprocessor also sets an energy consumption management strategy, such as dynamic voltage adjustment and sleep mode, to extend the overall battery life of the device. In this way, the flexible substrate technology, the highly integrated sensor array and the intelligent microprocessor are combined to achieve rapid and accurate detection of coagulation data.

[0044] In a possible embodiment, the non-invasive coagulation detection device 120 can be connected to other medical devices or health management platforms for communication to achieve data interoperability and sharing.

[0045] The cloud server 130 is used to store historical coagulation data, and input the first coagulation data and the user information to be tested into the coagulation function evaluation model, generate a first health hazard report, and feed it back to the mobile terminal, wherein the coagulation function evaluation model is trained based on the coagulation data set that annotates the coagulation function status and user information.

[0046] In this embodiment, deep learning models such as LSTM (Long Short-Term Memory), GRU (Gated Recurrent Unit), CNN (Convolutional Neural Network), etc. can be selected as the basic model for coagulation function evaluation, and the coagulation function status can be predicted through sequence modeling in combination with user information and coagulation data.

[0047] In this embodiment, the first coagulation data of the user to be tested is combined with the user information to perform a health risk assessment, and the collected coagulation data set is deeply mined and analyzed using big data and machine learning algorithms. The coagulation function assessment model is trained through self-learning and optimization of the model, and the coagulation function assessment model is used to perform health risks and identify abnormalities in the first coagulation data, thereby ensuring the reliability of the health risk assessment, discovering potential health risks and problems, and providing an accurate basis for early prediction and prognosis evaluation of the disease.

[0048] In addition, the cloud server 130 will feed back the first health hazard report to the mobile terminal for the user to be tested to view.

[0049] In one embodiment, please continue to refer to Figure 2 The cloud server 130 includes: a data processing module 131, which is used to perform data preprocessing operations on the first coagulation data, wherein the data preprocessing includes at least one of cleaning processing, denoising processing and normalization processing; a first coagulation function evaluation module 132, which is used to label the preprocessed first coagulation data according to the user information to be tested, and input the labeled first coagulation data into the coagulation function evaluation model to obtain the first coagulation function state; a first hidden danger evaluation module 133, which is used to perform health hidden danger analysis on the first coagulation function state according to the user information to be tested, and generate a first health hidden danger report.

[0050] In this embodiment, the data processing module 131 is responsible for receiving the first coagulation data of the user to be tested, and performing data preprocessing operations on the first coagulation data, so that the quality of the first coagulation data is guaranteed. Then the first coagulation function evaluation module 132 marks the preprocessed first coagulation data according to the user information to be tested, and inputs the marked first coagulation data into the coagulation function evaluation model. In this way, the first coagulation function status is obtained in combination with the user information to be tested, which improves the accuracy of the coagulation function status evaluation under individual differences. In addition, the first hidden danger evaluation module 133 performs health hidden danger analysis on the first coagulation function status, and also combines the user information to be tested, and can enhance the accuracy of the health hidden danger analysis according to the genetic medical history, living habits, height, weight and other information of the user to be tested.

[0051] In one embodiment, please continue to refer to Figure 2 The cloud server 130 also includes: an individual difference analysis module 134, which is used to construct a user portrait based on the user information to be tested, and analyze individual differences based on the user portrait; a verification module 135, which is used to perform coagulation function analysis on the historical coagulation data, determine the standard coagulation function state corresponding to the historical coagulation data, and calculate the predicted difference between the historical coagulation function state corresponding to the historical coagulation data and the standard coagulation function state; a calibration module 136, which is used to adjust the model parameters and model structure of the coagulation function evaluation model according to individual differences and predicted differences, so as to obtain a personalized coagulation function evaluation model for the user to be tested.

[0052] In this embodiment, the individual difference analysis module 134 constructs a user portrait according to the user information to be tested, and analyzes individual differences based on the user portrait, that is, the user portrait is constructed in combination with the user information to be tested, such as age, gender, height, weight, genetic information, living habits and other physical data. The dimensions of the user portrait include age, gender, BMI (Body Mass Index, body mass index) index (weight (kg) / height2 (m 2 )), exercise frequency (number of times / week), drinking status (whether drinking), smoking status (whether smoking), etc., to reflect individual differences. The verification module 135 performs coagulation function analysis on the historical coagulation data, which can be a manual verification analysis to determine the standard coagulation function state corresponding to the historical coagulation data, so that the predicted difference between the historical coagulation function state corresponding to the historical coagulation data and the standard coagulation function state can be reliably calculated. The calibration module 136 adjusts the model parameters and model structure of the coagulation function evaluation model according to individual differences and predicted differences to obtain a personalized coagulation function evaluation model for the user to be tested.

[0053] In this way, the coagulation function evaluation model is personalized calibrated and optimized to adapt to the individual differences of the users to be tested, and a personalized coagulation function evaluation model for the users to be tested is obtained. This adaptive calibration function of the cloud server 130 can automatically adjust the algorithm parameters and mechanisms according to the individual differences and historical data of the users to be tested to ensure the personalization and accuracy of the coagulation function evaluation results, and also improve the flexibility and universality of the system.

[0054] In a possible embodiment, the model parameters and model structure of the coagulation function evaluation model are adjusted, that is, different weights are assigned to different layers or nodes in the coagulation function evaluation model according to different features in the user portrait and the prediction differences of historical data, and Grid Search, Random Search or Bayesian Optimization and other methods are used to search for the optimal model parameter combination on the user's historical data, for example, the learning rate range [0.0001, 0.01], the batch size range [16, 128].

[0055] In a possible embodiment, the personalized coagulation function assessment model of the user to be tested can be verified to determine the accuracy and personalization of the coagulation function assessment result, wherein the verification indicators include accuracy, precision, recall rate, F1 score, etc., or the model performance before and after adjustment can be compared through A / B testing; and information feedback from doctors and users can be collected to further optimize the model; the model update frequency of the personalized coagulation function assessment model can be set, and the model can be updated regularly or on demand according to the coagulation number updated by the user to be tested.

[0056] The remote medical service system 140 is used to extract characteristic information from the first coagulation data, the historical coagulation data and the first health hazard report, and formulate a first health management plan for the user to be tested according to the mapping relationship between the characteristic information and the health management plan.

[0057] In this embodiment, the cloud server 130 can share and interact with the remote medical service system 140 through the remote data synchronization and processing function, and share the first coagulation data, historical coagulation data and first health hazard report of the user to be tested with the doctor or medical expert. The doctor or medical expert can remotely access the above data through a computer or mobile device, providing them with a comprehensive and accurate diagnosis basis, which helps to improve the quality of medical services, so that the doctor or medical expert can provide accurate and personalized medical consultation and guidance to the user to be tested, and feedback the formulated first health management plan to the user to be tested, realizing telemedicine, allowing the user to perform coagulation function testing at home, thereby saving medical resources and expenses and facilitating the user's medical treatment. At the same time, the doctor can remotely monitor and guide multiple users to be tested through the system, improving the efficiency of medical treatment.

[0058] In a possible embodiment, doctors or medical experts may send feedback and suggestions to the cloud server 130 through the remote medical service system 140 so that the cloud server 130 can further improve and optimize the coagulation function assessment model.

[0059] In one embodiment, the remote medical service system 140 supports an online video consultation function, so that the user to be tested can communicate with the doctor or medical expert face to face.

[0060] In one embodiment, the remote medical service system 140 supports multi-language services to meet the needs of users in different regions, thereby enhancing the scalability of the coagulation function health management platform.

[0061] Specifically, the characteristic information includes coagulation data trend characteristics and health risk characteristics. Figure 2 The telemedicine service system 140 includes: an access module 141, which is used to obtain the first coagulation data, the historical coagulation data and the first health hazard report; a first health management module 142, which is used to analyze the change trends of the first coagulation data and the historical coagulation data, obtain the trend characteristics of the coagulation data, and analyze the health hazards in the first health hazard report to obtain the health hazard characteristics, and generate a first health management plan according to the mapping relationship between the coagulation data trend characteristics, the health hazard characteristics and the health management plan, wherein the first health management plan includes at least one of diet suggestions, exercise suggestions, life habit suggestions and drug suggestions.

[0062] Among them, dietary recommendations include stopping the consumption of foods that affect coagulation function and recommending the intake of specific foods or nutrients, such as increasing foods rich in vitamin K to support normal coagulation function; exercise recommendations include providing exercise types and exercise duration based on the user's physical condition and exercise preferences; lifestyle recommendations include ensuring sleep quality, quitting smoking and limiting alcohol consumption; and drug recommendations include stopping the consumption of drugs that affect coagulation function and taking drugs that help restore coagulation function.

[0063] In this embodiment, the first health management plan is formulated in combination with the coagulation data trend characteristics and the health risk characteristics, thus ensuring the accuracy of the first health management plan.

[0064] In one embodiment, please continue to refer to Figure 2 The cloud server 130 also includes: a second health management module 137, which is used to input the first coagulation data, the first health hazard report, and the user information to be tested into the first health management model to obtain a second health management plan, wherein the first health management model is trained based on the first data set labeled with health suggestions, and the second health management plan includes at least one of diet suggestions, exercise suggestions, life habit suggestions, medical consultation guidance and drug suggestions.

[0065] It should be noted that the dietary advice, exercise advice, and lifestyle advice are as mentioned above and will not be repeated here. As for medical consultation guidance, for example, when the user's coagulation function is abnormal or the risk of health hazards is high, the user to be tested is guided to consult a doctor or professional medical personnel in a timely manner to obtain professional medical advice and treatment plans.

[0066] In addition, the first data set includes coagulation data with health advice, health risk reports, and user information.

[0067] In this embodiment, the second health management module 137 of the cloud server 130 combines the first coagulation data, the first health hazard report and the user information to be tested, and uses the first health management model to generate a health management plan, thereby ensuring the reliability of the obtained second health management plan.

[0068] It should also be noted that the cloud server 130 will feed back the second health management plan to the mobile terminal 110 so that the user to be tested can view personalized health suggestions in real time, which is convenient for the user to improve the coagulation function according to the suggestions.

[0069] In one embodiment, please continue to refer to Figure 2 The mobile terminal 110 also includes: an acquisition module 111, which is used to respond to the second detection operation and acquire a blood sample image of the fingertips of the user to be tested; an image analysis module 112, which is used to input the blood sample image into an image analysis model to obtain second coagulation data, wherein the image analysis model is trained based on a blood sample image set with annotated coagulation data, and the blood sample image set includes blood sample images under various light, skin color and shooting angles; a second coagulation function evaluation module 113, which is used to compare the second coagulation data with a preset coagulation data threshold, and determine the second coagulation function state according to the comparison result; a second hidden danger evaluation module 114, which is used to perform health hidden danger analysis on the second coagulation function state according to the user information to be tested, and generate a second health hidden danger report.

[0070] In this embodiment, the mobile terminal 110 provides a second detection operation, and can open the camera based on the second detection operation to capture the blood sample image of the fingertips of the user to be tested, thereby realizing instant non-invasive detection of coagulation data, and using the image analysis model to identify and analyze the image to obtain the second coagulation data, thereby ensuring the accuracy of the obtained coagulation data. In addition, when training the image analysis model, the differences in blood sample images of fingertips under various light, skin color and shooting angles are taken into account. Therefore, the accuracy of the model recognition and analysis is enhanced by using blood sample sample images under various light, skin color and shooting angles for training.

[0071] It should be noted that before the camera captures the blood sample image of the fingertips of the user to be tested, a higher image resolution needs to be set to ensure the clarity of the collected blood sample image and further ensure the accuracy of the image recognition result.

[0072] In this embodiment, the second coagulation data is directly compared with the preset coagulation data threshold, and the second coagulation function state is determined based on the comparison result, thereby achieving efficient detection of coagulation function. At the same time, the health hazard analysis of the second coagulation function state is performed in combination with the user information to be tested, thereby ensuring the reliability of the second health hazard report obtained.

[0073] It should also be noted that the mobile terminal 110 and the non-invasive coagulation detection device 120 can perform instant non-invasive coagulation data detection, but the mobile terminal 110 mainly predicts coagulation data by capturing the blood sample image of the fingertips of the user to be tested through a camera, which mainly relies on image processing and recognition technology, while the non-invasive coagulation detection device 120 has an internal integrated biosensor to predict coagulation data by collecting the physiological signals of the user to be tested. It is simple and quick to obtain coagulation data using the mobile terminal 110, and it is more reliable and accurate to obtain coagulation data using the non-invasive coagulation detection device 120.

[0074] In this way, combining the speed and convenience of the mobile terminal 110 and the high precision of the non-invasive coagulation detection device 120, the platform can provide more comprehensive, accurate and personalized coagulation function detection and health management services. The mobile terminal 110 is suitable for daily monitoring of the user to be tested, while the non-invasive coagulation detection device 120 ensures reliable data support when high-precision detection is required. This dual detection mechanism enhances the overall performance and user experience of the platform.

[0075] In one embodiment, please continue to refer to Figure 2 The mobile terminal 110 also includes: a third health management module 115, which is used to input the second coagulation data, the second health hazard report and the user information to be tested into the second health management model to obtain an initial health management plan, wherein the second health management model is trained based on the second data set labeled with health suggestions, and the initial health management plan includes at least one of diet suggestions, exercise suggestions, lifestyle suggestions, medical consultation guidance and drug suggestions; an audit module 116, which is used to audit the medical consultation guidance and drug suggestions. If the audit is passed, the initial health management plan is determined as the third health management plan; an update module 117, which is used to update the third health management plan in real time according to the latest second coagulation data, the second health hazard report and the user information to be tested.

[0076] Among them, dietary advice, exercise advice, lifestyle advice, medical consultation guidance and medication advice are mentioned above and will not be repeated here.

[0077] In this embodiment, the mobile terminal 110 intelligently generates personalized health reminders and treatment suggestions based on the second coagulation data of the user to be tested, the second health hazard report and the user information to be tested, which helps to enhance the user's health awareness and self-management ability and improve the user experience. In addition, considering the accuracy of the initial health management plan obtained by the mobile terminal 110, it is necessary to review it, such as expert system or manual review, especially suggestions involving medical consultation or drug management, which need to be reviewed by expert systems or medical professionals. Only after the review is passed can the third health management plan be obtained to ensure the accuracy and safety of the suggestions. In addition, with the accumulation of user data to be tested and the optimization of the algorithm, the third health management plan will be able to be updated and adjusted in real time according to the user's latest status.

[0078] It should be understood that the mobile terminal 110, the cloud server 130 and the telemedicine service system 140 can all generate health management plans. Among them, the mobile terminal 110 provides convenient one-click operation and automatic interpretation of results to generate health management plans, focusing on user-friendliness and convenience; the cloud server 130 generates high-level health management plans based on the storage and in-depth analysis of large-scale data, and can better discover potential coagulation characteristics and risks; the telemedicine service system 140 connects doctors and users to be tested, provides professional consultation and telemedicine services, and can provide users with more specific medical advice and treatment plans. In the health management plans generated by the mobile terminal 110, the cloud server 130 and the telemedicine service system 140, the reference data types and sources are different, so the specific health management plans obtained are different. For the users to be tested, they can make choices according to their needs and situations. For example, for daily monitoring and preliminary evaluation, the health management plan is obtained through the mobile terminal 110; for in-depth analysis and professional advice, the cloud server 130 obtains the health management plan; for emergency situations and real-time interaction, the health management plan is obtained based on the telemedicine service system 140. In this way, the three components complement each other to form a comprehensive non-invasive instant detection of coagulation function and personalized remote health management platform, further enhancing the health management experience of the users to be tested.

[0079] In a possible embodiment, data transmission is performed based on a secure encryption protocol and data transmission mechanism to ensure the security of data during transmission and storage, and only authenticated users and doctors can access and view the data.

[0080] As a possible embodiment, the mobile terminal 110 and the non-invasive coagulation detection device 120 can communicate through Bluetooth technology, Wi-Fi connection, wired connection, etc.; the mobile terminal 110 and the cloud server 130 can use the mobile communication network or Wi-Fi network to achieve communication connection, and use HTTPS (Hypertext Transfer Protocol Secure) to ensure the security and integrity of the data transmission process; the mobile terminal 110 and the remote medical service system 140 can use the mobile communication network or Wi-Fi network to achieve communication connection, and use the WebSocket (network socket) protocol to achieve two-way, full-duplex data transmission; the non-invasive coagulation detection device 120 and the cloud server 130 are connected using Wi-Fi or a wired network, and use the transmission control protocol / Internet protocol for data transmission to ensure the reliability and sequentiality of the data; the cloud server 130 and the remote medical service system 140 are connected through an internal network, and use HTTP (Hypertext Transfer Protocol Secure) based on HTTP The non-invasive coagulation detection device 120 and the telemedicine service system 140 communicate indirectly, with the mobile terminal 110 or the cloud server 130 acting as an intermediary for data transmission and sharing.

[0081] The above-mentioned coagulation function health management platform first responds to the first detection operation through the mobile terminal, generates a detection instruction and obtains the information of the user to be tested, then responds to the detection instruction through the non-invasive coagulation detection device, collects the physiological signal of the user to be tested, and obtains the first coagulation data according to the physiological signal analysis. Then, the cloud server inputs the first coagulation data and the user information to be tested into the coagulation function evaluation model to generate a first health hazard report. Finally, the telemedicine service system can extract the first coagulation data, the historical coagulation data and the characteristic information in the first health hazard report, and formulate a first health management plan for the user to be tested according to the mapping relationship between the characteristic information and the health management plan, integrates the mobile terminal, the non-invasive coagulation detection device, the cloud server and the telemedicine service system with data interconnection, and uses the mobile terminal to control the non-invasive coagulation detection device for detection, thereby realizing non-invasive instant detection of coagulation function, reducing the complexity of the detection operation, and combining the user information to be tested, using the coagulation function evaluation model to evaluate the health hazard, enhancing the accuracy of the coagulation function detection, so that the telemedicine service system can formulate a health management plan based on comprehensive and reliable coagulation data and health hazard reports, and achieve high-quality telemedicine guidance, thereby improving the user experience. In this way, the coagulation function health detection platform can be widely used in the fields of medical health, telemedicine, personalized health management, scientific research and teaching, etc.

[0082] See also Figure 3 , Figure 3 1 is a flow chart of a method for healthy management of coagulation function shown in an exemplary embodiment of the present application. It should be understood that this embodiment does not limit the implementation environment to which the method is applicable.

[0083] like Figure 3 As shown, in an exemplary embodiment, the coagulation function health management method includes at least steps S310 to S350, which are described in detail as follows:

[0084] Step S310, in response to the first detection operation, obtaining the user information, physiological signals and historical coagulation data of the user to be tested, wherein the user information to be tested includes genetic information, physiological information and habit information;

[0085] Step S320, inputting the physiological signal into a coagulation data prediction model to obtain first coagulation data, wherein the coagulation data prediction model is trained based on a signal set of labeled coagulation data, and the first coagulation data includes prothrombin time, activated partial thromboplastin time, thrombin time, fibrinogen concentration, and D-dimer concentration;

[0086] Step S330, annotating the first coagulation data according to the user information to be tested, and inputting the annotated first coagulation data into a coagulation function evaluation model to obtain a first coagulation function state, wherein the coagulation function evaluation model is trained based on the coagulation data set with the annotated coagulation function state and the user information;

[0087] Step S340, performing health risk analysis on the first coagulation function state according to the user information to be tested, and generating a first health risk report;

[0088] Step S350, extracting characteristic information from the first coagulation data, the historical coagulation data and the first health hazard report, and formulating a first health management plan for the user to be tested according to a mapping relationship between the characteristic information and the health management plan.

[0089] It should be noted that the coagulation function health management method provided in the above embodiment and the coagulation function health management platform provided in the above embodiment belong to the same concept, and the detailed contents of each step have been described in detail in the platform embodiment and will not be repeated here.

[0090] The present application also provides a computer-readable storage medium on which a computer program is stored. When the computer program is executed by a processor of a computer, the computer executes the above-mentioned coagulation function health management method. The computer-readable storage medium may be included in an electronic device, or may exist independently without being assembled into the electronic device.

[0091] It should be noted that the computer-readable medium shown in the embodiment of the present application can be a computer-readable signal medium or a computer-readable storage medium or any combination of the above two. The computer-readable storage medium can be, for example, an electrical, magnetic, optical, electromagnetic, infrared, or semiconductor system, device or device, or any combination of the above. More specific examples of computer-readable storage media can include, but are not limited to: an electrical connection with one or more wires, a portable computer disk, a hard disk, a random access memory (RAM), a read-only memory (ROM), an erasable programmable read-only memory (EPROM), a flash memory, an optical fiber, a portable compact disk read-only memory (CD-ROM), an optical storage device, a magnetic storage device, or any suitable combination of the above. In the present application, a computer-readable signal medium may include a data signal propagated in a baseband or as part of a carrier wave, wherein a computer-readable computer program is carried. This propagated data signal can take a variety of forms, including but not limited to an electromagnetic signal, an optical signal, or any suitable combination of the above. A computer-readable signal medium may also be any computer-readable medium other than a computer-readable storage medium, which may send, propagate or transmit a program for use by or in conjunction with an instruction execution system, apparatus or device. A computer program contained on a computer-readable medium may be transmitted using any appropriate medium, including but not limited to: wireless, wired, etc., or any suitable combination of the above.

[0092] The flowcharts and block diagrams in the accompanying drawings illustrate the possible architecture, functions and operations of the systems, methods and computer program products according to various embodiments of the present invention. Among them, each box in the flowchart or block diagram can represent a module, a program segment, or a part of the code, and the above-mentioned module, program segment, or a part of the code contains one or more executable instructions for implementing the specified logical function. It should also be noted that in some alternative implementations, the functions marked in the box can also occur in a different order from the order marked in the accompanying drawings. For example, two boxes represented in succession can actually be executed substantially in parallel, and they can sometimes be executed in the opposite order, depending on the functions involved. It should also be noted that each box in the block diagram or flowchart, and the combination of boxes in the block diagram or flowchart, can be implemented with a dedicated hardware-based system that performs a specified function or operation, or can be implemented with a combination of dedicated hardware and computer instructions.

[0093] The units involved in the embodiments of the present invention may be implemented by software or hardware, and the units described may also be arranged in a processor. The names of these units do not, in some cases, limit the units themselves.

[0094] The above embodiments are merely illustrative of the principles and effects of the present invention, and are not intended to limit the present invention. Anyone familiar with the technology may modify or change the above embodiments without violating the spirit and scope of the present invention. Therefore, all equivalent modifications or changes made by a person of ordinary skill in the art without departing from the spirit and technical ideas disclosed by the present invention shall still be covered by the claims of the present invention.

Claims

1. A coagulation function health management platform, characterized in that: The platform includes a data interconnected mobile terminal, a non-invasive coagulation detection device, a cloud server and a telemedicine service system; The mobile terminal is used to respond to the first detection operation, generate a detection instruction and send it to the non-invasive coagulation detection device, and obtain the user information to be tested and send it to the cloud server; The non-invasive coagulation detection device is used to respond to the detection instruction, collect physiological signals of the user to be tested, obtain first coagulation data according to the physiological signal analysis, and send the first coagulation data to the cloud server; The cloud server is used to store historical coagulation data, and input the first coagulation data and the user information to be tested into a coagulation function evaluation model to generate a first health hazard report, and feed it back to the mobile terminal, wherein the coagulation function evaluation model is trained based on a coagulation data set annotated with coagulation function status and user information; The remote medical service system is used to extract characteristic information from the first coagulation data, the historical coagulation data and the first health hazard report, and formulate a first health management plan for the user to be tested based on a mapping relationship between the characteristic information and the health management plan.

2. The blood coagulation function health management platform according to claim 1, characterized in that: The non-invasive coagulation detection device comprises: A sensor module, used for collecting the physiological signals, wherein the physiological signals include impedance signals, blood flow resistance signals and piezoelectric signals; A signal processing module, used for performing signal preprocessing operations on the impedance signal, the blood flow resistance signal and the piezoelectric signal, wherein the signal preprocessing operations include at least one of signal amplification processing, filtering processing, denoising processing and correction processing; A data analysis module is used to input the pre-processed impedance signal, the blood flow resistance signal and the piezoelectric signal into a coagulation data prediction model to obtain the first coagulation data, wherein the coagulation data prediction model is trained based on a signal set of labeled coagulation data, and the first coagulation data includes prothrombin time, activated partial thromboplastin time, thrombin time, fibrinogen concentration and D-dimer concentration.

3. The blood coagulation function health management platform according to claim 1, characterized in that: The cloud server includes: A data processing module, used for performing data preprocessing operation on the first coagulation data, wherein the data preprocessing includes at least one of cleaning processing, denoising processing and normalization processing; A first coagulation function evaluation module, used for labeling the preprocessed first coagulation data according to the user information to be tested, and inputting the labeled first coagulation data into a coagulation function evaluation model to obtain a first coagulation function state, wherein the user information to be tested includes genetic information, physiological information and habit information; The first hidden danger assessment module is used to perform health hidden danger analysis on the first coagulation function state according to the user information to be tested, and generate the first health hidden danger report.

4. The blood coagulation function health management platform according to claim 1, characterized in that: The characteristic information includes coagulation data trend characteristics and health hazard characteristics, and the remote medical service system includes: An access module, used for obtaining the first coagulation data, the historical coagulation data and the first health hazard report; The first health management module is used to analyze the change trends of the first coagulation data and the historical coagulation data to obtain the trend characteristics of the coagulation data, and to analyze the health hazards in the first health hazard report to obtain the health hazard characteristics, and to generate the first health management plan based on the mapping relationship between the coagulation data trend characteristics, the health hazard characteristics and the health management plan, wherein the first health management plan includes at least one of diet suggestions, exercise suggestions, life habit suggestions and drug suggestions.

5. The blood coagulation function health management platform according to claim 3, characterized in that: The cloud server also includes: An individual difference analysis module, used to construct a user portrait according to the user information to be tested, and analyze individual differences based on the user portrait; a verification module, configured to perform a coagulation function analysis on the historical coagulation data, determine a standard coagulation function state corresponding to the historical coagulation data, and calculate a predicted difference between the historical coagulation function state corresponding to the historical coagulation data and the standard coagulation function state; The calibration module is used to adjust the model parameters and model structure of the coagulation function evaluation model according to the individual differences and the predicted differences, so as to obtain a personalized coagulation function evaluation model for the user to be tested.

6. The blood coagulation function health management platform according to claim 3, characterized in that: The cloud server also includes: The second health management module is used to input the first coagulation data, the first health hazard report, and the user information to be tested into a first health management model to obtain a second health management plan, wherein the first health management model is trained based on a first data set marked with health advice, and the second health management plan includes at least one of diet advice, exercise advice, living habit advice, medical consultation guidance, and drug advice.

7. The blood coagulation function health management platform according to any one of claims 1 to 6, characterized in that: The mobile terminal further includes: A collection module, used for collecting a blood sample image of a fingertip of a user to be tested in response to a second detection operation; An image analysis module, used for inputting the blood sample image into an image analysis model to obtain second coagulation data, wherein the image analysis model is trained based on a blood sample image set annotated with coagulation data, and the blood sample image set includes blood sample images under various light, skin color and shooting angles; a second coagulation function evaluation module, configured to compare the second coagulation data with a preset coagulation data threshold, and determine a second coagulation function state according to the comparison result; The second hidden danger assessment module is used to perform health hidden danger analysis on the second coagulation function state according to the user information to be tested, and generate a second health hidden danger report.

8. The blood coagulation function health management platform according to claim 7, characterized in that: The mobile terminal further includes: a third health management module, configured to input the second coagulation data, the second health hazard report, and the user information to be tested into a second health management model to obtain an initial health management plan, wherein the second health management model is trained based on a second data set labeled with health advice, and the initial health management plan includes at least one of diet advice, exercise advice, lifestyle advice, medical consultation guidance, and medication advice; An audit module, used to audit the medical consultation guidance and the drug recommendation, and if the audit is passed, determine the initial health management plan as the third health management plan; The updating module is used to update the third health management program in real time according to the latest second coagulation data, the second health hazard report and the user information to be tested.

9. A method for healthy management of coagulation function, characterized in that: The method comprises: In response to the first detection operation, obtaining the user information, physiological signals and historical coagulation data of the user to be tested, wherein the user information to be tested includes genetic information, physiological information and habit information; Inputting the physiological signal into a coagulation data prediction model to obtain the first coagulation data, wherein the coagulation data prediction model is trained based on a signal set of labeled coagulation data, and the first coagulation data includes prothrombin time, activated partial thromboplastin time, thrombin time, fibrinogen concentration, and D-dimer concentration; Annotating the first coagulation data according to the user information to be tested, and inputting the annotated first coagulation data into a coagulation function evaluation model to obtain a first coagulation function state, wherein the coagulation function evaluation model is trained based on a coagulation data set with annotated coagulation function states and user information; Performing a health risk analysis on the first coagulation function state according to the user information to be tested, and generating the first health risk report; Extract characteristic information from the first coagulation data, the historical coagulation data, and the first health hazard report, and formulate a first health management plan for the user to be tested based on a mapping relationship between the characteristic information and the health management plan.

10. A computer-readable storage medium, characterized in that: A computer program is stored thereon, and when the computer program is executed by a processor of a computer, the computer is caused to execute the blood coagulation function health management method as described in claim 9.

Citation Information

Cited By

  • Intelligent monitoring system for pediatric severe nursing

    CN121489496A